期刊文献+

双阴性T细胞检测在自身免疫性淋巴细胞增生综合征诊断中的重要性:1例报告并文献复习 被引量:1

The importance of double-negative T cells in the diagnosis of autoimmune lymphoproliferative syndrome:a case report and review of the literatures
下载PDF
导出
摘要 目的提高对自身免疫性淋巴细胞增生综合征(ALPS)的认识、减少漏诊,并认识TCRαβ+CD3+CD4-CD8-T细胞(DNTs)检测在本病诊断中的重要性。方法对1例ALPS患者资料进行临床分析及文献复习。结果该例患儿反复发生溶血性贫血、血小板减少。通过颈部淋巴结活检、骨髓形态及病理、染色体核型及DNTs比例、免疫球蛋白定量检测,发现患儿病史长达7年余,反复发生溶血性贫血、血小板减少、淋巴结及肝脾肿大。外周血DNTs比例为8.99%(>5%),IgG升高。糖皮质激素治疗有效。结论临床上出现无法解释的淋巴结肿大、肝脾肿大及自身免疫性溶血、血小板减少的患者应考虑ALPS可能,外周血DNTs比例检测有助于ALPS的早期诊断。 Objective To better understand the importance of TCRαβ + CD3 + CD4-CD8-T-cell (DNTs) in the diagnosis of autoimmune lymphoproliferative syndrome (ALPS) and reduce the missed diagnosis.Methods A case diagnosed as ALPS was reported and the related articles were reviewed.Results The patient had a 7-year history and presented with recurrent hemolytic anemia,thrombocytopenia,lymphadenopathy and hepatosplenomegaly.Cervical lymph node biopsy,bone marrow aspiration and biopsy,chromosome karyotype,double-negative T cells (DNTs) and immunoglobulin detection were performed.The ratio of DNTs was 8.99% with an increased level of serum IgG.The therapeutic effect of glucocorticoid was positive.Conclusions ALPS should be considered when children has tmexplained lyrnphadenopathy,hepatosplenomegaly or autoimmtme hemolysis.The ratio of DNTs should be evaluated to make an earlier diagnosis.
机构地区 中国医学科学院
出处 《中国小儿血液与肿瘤杂志》 CAS 2013年第5期226-229,共4页 Journal of China Pediatric Blood and Cancer
基金 卫生部部属(管)医院2010-2012学科重点项目
关键词 自身免疫 溶血性贫血 双阴性T细胞 Autoimmune Hemolytic anemia Double-negative T cells
  • 相关文献

参考文献16

  • 1Canale VC,Smith CH.Chronic lymphadenopathy simulating malignant lymphoma.J Pediatr,1967,70:891-899.
  • 2Oliveira JB,Bleesing JJ,Dianzani U,et al.Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome(ALPS):report from the 2009 NIH International Workshop.Blood,2010,l16:e35-e40.
  • 3Magerus-Chatinet A,Stolzenherg MC,Loffredo MS,et al.FAS-L,IL-10,and double-negative CD4-CD8-TCR alpha/beta + T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated wich FAS loss of funocion.Blood,2009,113:3027-3030.
  • 4Caminha I,Fleisher TA,Homung RL,et al.Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoprolifemtive syndrome.J Allergy Clin lmmunol,2010,125:946-949.
  • 5Infante A J,Britton HA,DeNapoli T,et al.The clinical spectrum in a large kindred with autoimmune lymphoproliferafive syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.J Pediatr,1998,133:629-633.
  • 6Teachey DT,Seif AE,Grupp SA.Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).Br J Haematol,2010,148:205-216.
  • 7Fleisher TA,Straus SE,Bleesing JJ.A genetic disorder of lymphocyte apoptosis involving the fas pathway:the autoimmune lymphoproliferative syndrome.Curr Allergy Asthma Rep,2001,1:534-540.
  • 8余春梅,张宇,邹庆,唐雪梅,于洁,赵晓东.FAS基因突变导致自身免疫性淋巴细胞增生综合征(ALPS)一例[J].免疫学杂志,2010,26(10):883-887. 被引量:4
  • 9Seif AE,Manno CS,Grupp SA,et al.Testing patients with Evans syndrome for the Autoimmune Lymphoprolifemtive Syndrome (ALPS):results of a large multi-institutional clinical trial (ASPHO supplement).Pediatric Blood & Cancer,2008,50:S22-S23.
  • 10Seif AE,Manno CS,Sheen C,et al.Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome:a multi-institutional study.Blood,2010,115:2142-2145.

二级参考文献10

  • 1Bleesing JJ, Brown MR, Straus SE, et al.Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome[J]. Blood, 2001, 98(8):2466-2473.
  • 2Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis[J]. Blood, 2001, 98(1):194-200.
  • 3Oliveira JB, Bleesing J J, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome: report from the 2009 NIH International Workshop[J]. Blood, 2010, Jun 10. [Epub ahead of print].
  • 4Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways [J]. Cell Death and Differentiation, 2003, 10: 124-133.
  • 5Rieux-Laucat F, Blach e re S, Danielan S,et al. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations [J]. Blood, 1999, 94: 2575-2582.
  • 6Le Deist F, Fischer A. Autoimmune lymphoproliferative syndrome. Available online at http://www.orpha.net. 2001, Accessed 3-17-09.
  • 7Raif S G, MD (Cochair), Luigi DN, et al. Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee [J]. J Allergy Clin Immunol, 2007, 120 (4): 776-794.
  • 8Christine E J, Roxanne E F, Amy P H, et al. Autoimmune Lymphoproliferative Syndrome with Defective Fas: Genotype Influences Penetrance [J]. Am J Hum Genet, 1999, 64: 1002-1014.
  • 9Nagata S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model [J]. J Hum Genet, 1998, 43(1): 2-8.
  • 10Bleesing J J, Straus SE, Fleisher TA. Autoimmune lymphoproliferative syndrome, a human disorder of abnormal lymphocyte survival [J]. Pediatr Clin North Am, 2000, 47 (6): 1291-1310.

共引文献3

同被引文献10

  • 1Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) [J]. BrJ Haematol, 2010, 148(2): 205-216.
  • 2Bleesing J J, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome[ J ]. Blood, 2001, 98(8): 2466-2473.
  • 3Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations mad defective lymphocyte apoptosis [J]. Blood, 2001, 98( 1 ) : 194-200.
  • 4Oliveira JB, Bleesing J J, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphopwliferative syndrome(ALPS) : report from the 2009 NIH International Workshop [J]. Blood, 2010, 116 (14) : 35-40.
  • 5Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome[J]. Cell, 1995, 81(6) : 935-946.
  • 6Seif AE, Manno CS, Sheen C, et al. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study [J]. Blood, 2010, 115 (11 ) : 2142-2145.
  • 7罗勇,刘纯义,黄卫东,王世俊,黄少文.自身免疫性淋巴细胞增生综合征1例报告[J].中国实用儿科杂志,2008,23(11):874-874. 被引量:2
  • 8王慧涵,杨威,常筱颖,王晓斌,刘卓刚.Castleman病26例[J].白血病.淋巴瘤,2009,18(11):663-665. 被引量:5
  • 9余春梅,张宇,邹庆,唐雪梅,于洁,赵晓东.FAS基因突变导致自身免疫性淋巴细胞增生综合征(ALPS)一例[J].免疫学杂志,2010,26(10):883-887. 被引量:4
  • 10黄礼彬,张丽丹,柯志勇,徐玲玲,刘茵,王卓,罗学群.自身免疫性淋巴细胞增殖综合征1例报告并文献复习[J].中国实用儿科杂志,2011,26(2):121-124. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部